Literature DB >> 30380007

Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle.

Lauren A Biwer1, Mary C Wallingford1,2, Iris Z Jaffe1.   

Abstract

The mineralocorticoid receptor (MR) is indispensable for survival through its critical role in maintaining blood pressure in response to sodium scarcity or bleeding. Activation of MR by aldosterone in the kidney controls water and electrolyte homeostasis. This review summarizes recent advances in our understanding of MR function, specifically in vascular endothelial and smooth muscle cells. The evolving roles for vascular MR are summarized in the areas of (i) vascular tone regulation, (ii) thrombosis, (iii) inflammation, and (iv) vascular remodeling/fibrosis. Synthesis of the data supports the concept that vascular MR does not contribute substantially to basal homeostasis but rather, MR is poised to be activated when the vasculature is damaged to coordinate blood pressure maintenance and wound healing. Specifically, MR activation in the vascular wall promotes vasoconstriction, inflammation, and exuberant vascular remodeling with fibrosis. A teleological model is proposed in which these functions of vascular MR may have provided a critical evolutionary survival advantage in the face of mechanical vascular injury with bleeding. However, modern lifestyle is characterized by physical inactivity and high fat/high sodium diet resulting in diffuse vascular damage. Under these modern conditions, diffuse, persistent and unregulated activation of vascular MR contributes to post-reproductive cardiovascular disease in growing populations with hypertension, obesity, and advanced age.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30380007      PMCID: PMC6331708          DOI: 10.1093/ajh/hpy158

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  93 in total

1.  Placental growth factor mediates aldosterone-dependent vascular injury in mice.

Authors:  Iris Z Jaffe; Brenna G Newfell; Mark Aronovitz; Najwa N Mohammad; Adam P McGraw; Roger E Perreault; Peter Carmeliet; Afshin Ehsan; Michael E Mendelsohn
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 2.  Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension.

Authors:  Michael F O'Rourke; Wilmer W Nichols
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

3.  Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction.

Authors:  Alexandre Gueret; Najah Harouki; Julie Favre; Guillaume Galmiche; Lionel Nicol; Jean-Paul Henry; Marie Besnier; Christian Thuillez; Vincent Richard; Peter Kolkhof; Paul Mulder; Frédéric Jaisser; Antoine Ouvrard-Pascaud
Journal:  Hypertension       Date:  2016-02-22       Impact factor: 10.190

Review 4.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.

Authors:  Maria-Christina Zennaro; Fabio Fernandes-Rosa
Journal:  J Endocrinol       Date:  2017-03-27       Impact factor: 4.286

5.  Rescue of the mineralocorticoid receptor knock-out mouse.

Authors:  M Bleich; R Warth; M Schmidt-Hieber; A Schulz-Baldes; P Hasselblatt; D Fisch; S Berger; K Kunzelmann; W Kriz; G Schütz; R Greger
Journal:  Pflugers Arch       Date:  1999-08       Impact factor: 3.657

6.  Eplerenone suppresses neointimal formation after coronary stent implantation in swine.

Authors:  Kohei Wakabayashi; Hiroshi Suzuki; Takatoshi Sato; Yoshitaka Iso; Takashi Katagiri; Youichi Takeyama
Journal:  Int J Cardiol       Date:  2005-07-14       Impact factor: 4.164

7.  Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Shlomo Keidar; Tony Hayek; Marielle Kaplan; Elsa Pavlotzky; Shadi Hamoud; Raymond Coleman; Michael Aviram
Journal:  J Cardiovasc Pharmacol       Date:  2003-06       Impact factor: 3.105

8.  Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice.

Authors:  Afshin Ehsan; Adam P McGraw; Mark J Aronovitz; Carol Galayda; Michael S Conte; Richard H Karas; Iris Z Jaffe
Journal:  J Thorac Cardiovasc Surg       Date:  2012-09-13       Impact factor: 5.209

9.  Endothelial Mineralocorticoid Receptor Mediates Parenchymal Arteriole and Posterior Cerebral Artery Remodeling During Angiotensin II-Induced Hypertension.

Authors:  Janice M Diaz-Otero; Courtney Fisher; Kelsey Downs; M Elizabeth Moss; Iris Z Jaffe; William F Jackson; Anne M Dorrance
Journal:  Hypertension       Date:  2017-10-03       Impact factor: 10.190

10.  Sex-Specific Mechanisms of Resistance Vessel Endothelial Dysfunction Induced by Cardiometabolic Risk Factors.

Authors:  Ana P Davel; Qing Lu; M Elizabeth Moss; Sitara Rao; Imran J Anwar; Jennifer J DuPont; Iris Z Jaffe
Journal:  J Am Heart Assoc       Date:  2018-02-16       Impact factor: 5.501

View more
  9 in total

Review 1.  Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms.

Authors:  Michael J Allingham; Priyatham S Mettu; Scott W Cousins
Journal:  Exp Eye Res       Date:  2019-08-31       Impact factor: 3.467

Review 2.  The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease.

Authors:  M Elizabeth Moss; Brigett Carvajal; Iris Z Jaffe
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

3.  Myeloid Mineralocorticoid Receptor Transcriptionally Regulates P-Selectin Glycoprotein Ligand-1 and Promotes Monocyte Trafficking and Atherosclerosis.

Authors:  Joshua J Man; Qing Lu; M Elizabeth Moss; Brigett Carvajal; Wendy Baur; Amanda E Garza; Roy Freeman; Marina Anastasiou; Njabulo Ngwenyama; Gail K Adler; Pilar Alcaide; Iris Z Jaffe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-07       Impact factor: 8.311

4.  PKCδ Mediates Mineralocorticoid Receptor Activation by Angiotensin II to Modulate Smooth Muscle Cell Function.

Authors:  Qing Lu; Ana P Davel; Adam P McGraw; Sitara P Rao; Brenna G Newfell; Iris Z Jaffe
Journal:  Endocrinology       Date:  2019-09-01       Impact factor: 4.736

5.  Mineralocorticoid receptor blockade normalizes coronary resistance in obese swine independent of functional alterations in Kv channels.

Authors:  Adam G Goodwill; Hana E Baker; Gregory M Dick; Patricia E McCallinhart; Chastidy A Bailey; Scott M Brown; Joshua J Man; Darla L Tharp; Hannah E Clark; Bianca S Blaettner; Iris Z Jaffe; Douglas K Bowles; Aaron J Trask; Johnathan D Tune; Shawn B Bender
Journal:  Basic Res Cardiol       Date:  2021-05-20       Impact factor: 17.165

6.  Mineralocorticoid Receptor in Smooth Muscle Contributes to Pressure Overload-Induced Heart Failure.

Authors:  Seung Kyum Kim; Lauren A Biwer; M Elizabeth Moss; Joshua J Man; Mark J Aronovitz; Gregory L Martin; Francisco J Carrillo-Salinas; Ane M Salvador; Pilar Alcaide; Iris Z Jaffe
Journal:  Circ Heart Fail       Date:  2021-02-01       Impact factor: 8.790

7.  Mineralocorticoid and Estrogen Receptors in Endothelial Cells Coordinately Regulate Microvascular Function in Obese Female Mice.

Authors:  Lauren A Biwer; Brigett V Carvajal; Qing Lu; Joshua J Man; Iris Z Jaffe
Journal:  Hypertension       Date:  2021-05-03       Impact factor: 9.897

8.  Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease.

Authors:  Lucas Liaudet; Csaba Szabo
Journal:  Crit Care       Date:  2020-06-08       Impact factor: 9.097

Review 9.  Oxidative Stress and Vascular Damage in the Context of Obesity: The Hidden Guest.

Authors:  Ernesto Martínez-Martínez; Francisco V Souza-Neto; Sara Jiménez-González; Victoria Cachofeiro
Journal:  Antioxidants (Basel)       Date:  2021-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.